|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Articles |
Unidad de Investigación and Servicio de Nefrología1 Hospital Universitario La Paz; Unidad de Biología Molecular2 and Servicio de Nefrología3 Hospital Universitario de la Princesa; Laboratory of Renal and Vascular Research4 Fundación Jiménez Díaz; Centro de Biología Molecular Severo Ochoa5 CSIC-UAM, Cantoblanco, Madrid, Spain
Footnotes
a All the authors belong to the Instituto Reina Sofía de Investigaciones Nefrológicas.
Correspondence to: R. Selgas, Servicio de Nefrología, Hospital Universitario La Paz, Castellana, 261, 28046, Madrid, Spain. rselgas.hulp{at}salud.madrid.org
Animal models of peritoneal dialysis fluid (PDF) exposure are key tools
in the study of mechanisms involved in alterations of the peritoneal membrane
and in the design of therapies. We recently developed a mouse model of chronic
peritoneal exposure to high glucose dialysate. Herein, we make a sequential
analysis of the effects of glucose-based PDF on mouse peritoneal membrane and
on mesothelium. We demonstrate that chronic exposure to PDF induces thickness
and fibrosis of the peritoneal membrane in a time-dependent manner. We also
show that mesothelial cells progressively detach and lose cytokeratin
expression. In addition, we demonstrate that some mesothelial cells invade the
submesothelial space, where they appear as cytokeratin- and alpha-smooth
muscle actin-positive cells. These findings demonstrate that
epithelial-to-mesenchymal transition (EMT) of mesothelial cells takes place in
mouse peritoneum exposed to PDF, validating this model for the study of
effects of drugs on the EMT process as a therapy for peritoneal
deterioration.
KEY WORDS: Mesothelial cell; epithelial-to-mesenchymal transition; mice model of peritoneal dialysis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |